NUS Links:
Home › News & Events › News & Media
21 December 2022
Non-Hodgkin’s lymphoma is a common form of blood cancer with a high proportion of patients either developing treatment...
20 December 2022
A/Prof Koh Liang Piu, member of the N2CR Tissue-Specific Carcinogenesis theme, helped to develop a cell selection techni...
(image credit: The Straits Times) For the past two decades, Prof Too has played a tremendous role in strengthenin...
19 December 2022
Every year, analytics company Clarivate publishes a list of highly cited researchers who have constantly produced high i...
7 December 2022
Every year Stanford University publishes a list of highly cited scientists based on citation metrics from Scopus. The li...
30 November 2022
N2CR member Associate Professor Too Heng-Phon, who co-foundered biotech firm MiRXES with two of his former PhD students,...
24 November 2022
N2CR members, A/Prof Edward Chow and Dr Anand Jeyasekharan have found a method to create a more personalized combination...
26 October 2022
Hepatocellular carcinoma (HCC) remains difficult to treat due to a lack of effective treatment options. While various dr...
Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is an aggressive and poorly understood dis...
